| Original language | English (US) |
|---|---|
| Pages (from-to) | 70-92 |
| Number of pages | 23 |
| Journal | Neuromuscular Disorders |
| Volume | 30 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2020 |
Keywords
- Antisynthetase syndrome
- Autoantibodies
- Classification
- Dermatomyositis
- Myositis
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Neurology
- Clinical Neurology
- Genetics(clinical)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
239th ENMC International Workshop : Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018. / ENMC 239th Workshop Study Group.
In: Neuromuscular Disorders, Vol. 30, No. 1, 01.2020, p. 70-92.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - 239th ENMC International Workshop
T2 - Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
AU - ENMC 239th Workshop Study Group
AU - Mammen, Andrew L.
AU - Allenbach, Yves
AU - Stenzel, Werner
AU - Benveniste, Olivier
AU - Allenbach, Dr Yves
AU - Benveniste, Dr Olivier
AU - Bleecker, Dr Jan De
AU - Boyer, Dr Olivier
AU - Casciola-Rosen, Dr Livia
AU - Christopher-Stine, Dr Lisa
AU - Damoiseaux, Dr Jan
AU - Gitiaux, Dr Cyril
AU - Fujimoto, Dr Manabu
AU - Lamb, Dr Janine
AU - Landon-Cardinal, Dr Océane
AU - Ingrid, Dr Ingrid
AU - Mammen, Dr Andrew
AU - Nishino, Dr Ichizo
AU - Radke, Dr Josefine
AU - Selva-O'Callaghan, Dr Albert
AU - Stenzel, Dr Werner
AU - Vencovsky, Dr Jiri
AU - de Visser, Dr Marianne
AU - Wang, Dr Guochun
AU - Wedderburn, Dr Lucy
AU - Werth, Dr Victoria
N1 - Funding Information: This Workshop was made possible thanks to the financial support of the European Neuromuscular Centre (ENMC) and ENMC main sponsors: Funding Information: This research was also supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; ZIA AR041203 ). Funding Information: This Workshop was made possible thanks to the financial support of the European Neuromuscular Centre (ENMC) and ENMC main sponsors:, - Association Fran?aise contre les Myopathies (France), - Deutsche Gesellschaft f?r Muskelkranke (Germany), - Muscular Dystrophy Campaign (UK), - Muskelsvindfonden (Denmark), - Prinses Beatrix Spierfonds (The Netherlands), - Schweizerische Stiftung f?r die Erforschung der Muskelkrankheiten (Switzerland), - Telethon Foundation (Italy), - Spierziekten Nederland (The Netherlands) and Associated members:, - Finnish Neuromuscular Association (Finland), - ?sterreichische Muskelforschung (Austria), With a special thanks to members of the ENMC Company Forum, - Sanofi Genzyme, - Santhera Pharmaceuticals, - Amicus Therapeutics, - CSL Behring LLC, - Ionis Pharmaceuticals, - Perkin Elmer/Wallac Oy, - AveXis Switzerland GmbH, - Biogen International GmbH, - Hoffmann-la-Roche, - Sanquin Plasma Products, This research was also supported by the Intramural Research Programs of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; ZIA AR041203).
PY - 2020/1
Y1 - 2020/1
KW - Antisynthetase syndrome
KW - Autoantibodies
KW - Classification
KW - Dermatomyositis
KW - Myositis
UR - http://www.scopus.com/inward/record.url?scp=85076532521&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076532521&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2019.10.005
DO - 10.1016/j.nmd.2019.10.005
M3 - Article
C2 - 31791867
AN - SCOPUS:85076532521
SN - 0960-8966
VL - 30
SP - 70
EP - 92
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 1
ER -